Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Apathy in Alzheimer's disease : A neurocircuitry based perspective

Mehak, Sonam Fathima ; Shivakumar, Apoorva Bettagere ; Saraf, Vikyath ; Johansson, Maurits LU and Gangadharan, Gireesh (2023) In Ageing Research Reviews 87.
Abstract

In addition to memory deficits and other cognitive disturbances, patients with Alzheimer's disease (AD) experience neuropsychiatric symptoms, notably apathy, which is a state of impaired motivation observed by deficits in goal directed behavior. Apathy is a multifaceted neuropsychiatric condition and appears to be a prognostic indicator, correlating with the progression of AD. Strikingly, recent studies point out that the neurodegenerative pathology of AD may drive apathy independent of cognitive decline. These studies also highlight that neuropsychiatric symptoms, in particular apathy, might manifest early in AD. Here, we review the current understanding of the neurobiological underpinnings of apathy as a neuropsychiatric symptom of... (More)

In addition to memory deficits and other cognitive disturbances, patients with Alzheimer's disease (AD) experience neuropsychiatric symptoms, notably apathy, which is a state of impaired motivation observed by deficits in goal directed behavior. Apathy is a multifaceted neuropsychiatric condition and appears to be a prognostic indicator, correlating with the progression of AD. Strikingly, recent studies point out that the neurodegenerative pathology of AD may drive apathy independent of cognitive decline. These studies also highlight that neuropsychiatric symptoms, in particular apathy, might manifest early in AD. Here, we review the current understanding of the neurobiological underpinnings of apathy as a neuropsychiatric symptom of AD. Specifically, we highlight the neural circuits and brain regions recognized to be correlated with the apathetic symptomatology. We also discuss the current evidence that supports the notion that apathy and cognitive deficits may develop as independent but concurrent phenomena driven by AD pathology, suggesting its efficacy as an additional outcome measure in Alzheimer's disease clinical trials. The current and prospective therapeutic interventions for apathy in AD from a neurocircuitry based perspective are also reviewed.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Alzheimer's disease, Apathy, Neural circuits, Neuropsychiatric symptoms, Subcortical circuits
in
Ageing Research Reviews
volume
87
article number
101891
publisher
Elsevier
external identifiers
  • pmid:36871779
  • scopus:85149902903
ISSN
1568-1637
DOI
10.1016/j.arr.2023.101891
language
English
LU publication?
yes
id
46449b62-6c6e-4244-81dd-895816565864
date added to LUP
2023-04-24 11:20:44
date last changed
2024-06-16 04:43:30
@article{46449b62-6c6e-4244-81dd-895816565864,
  abstract     = {{<p>In addition to memory deficits and other cognitive disturbances, patients with Alzheimer's disease (AD) experience neuropsychiatric symptoms, notably apathy, which is a state of impaired motivation observed by deficits in goal directed behavior. Apathy is a multifaceted neuropsychiatric condition and appears to be a prognostic indicator, correlating with the progression of AD. Strikingly, recent studies point out that the neurodegenerative pathology of AD may drive apathy independent of cognitive decline. These studies also highlight that neuropsychiatric symptoms, in particular apathy, might manifest early in AD. Here, we review the current understanding of the neurobiological underpinnings of apathy as a neuropsychiatric symptom of AD. Specifically, we highlight the neural circuits and brain regions recognized to be correlated with the apathetic symptomatology. We also discuss the current evidence that supports the notion that apathy and cognitive deficits may develop as independent but concurrent phenomena driven by AD pathology, suggesting its efficacy as an additional outcome measure in Alzheimer's disease clinical trials. The current and prospective therapeutic interventions for apathy in AD from a neurocircuitry based perspective are also reviewed.</p>}},
  author       = {{Mehak, Sonam Fathima and Shivakumar, Apoorva Bettagere and Saraf, Vikyath and Johansson, Maurits and Gangadharan, Gireesh}},
  issn         = {{1568-1637}},
  keywords     = {{Alzheimer's disease; Apathy; Neural circuits; Neuropsychiatric symptoms; Subcortical circuits}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{Ageing Research Reviews}},
  title        = {{Apathy in Alzheimer's disease : A neurocircuitry based perspective}},
  url          = {{http://dx.doi.org/10.1016/j.arr.2023.101891}},
  doi          = {{10.1016/j.arr.2023.101891}},
  volume       = {{87}},
  year         = {{2023}},
}